Spencer D. Dorn, David Wei, Joel F. Farley, Nilay D. Shah, Nicholas J

Slides:



Advertisements
Similar presentations
MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.
Advertisements

Douglas K. Rex, MD  Clinical Gastroenterology and Hepatology 
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Alan N. Desmond, Sebastian McWilliams, Michael M
Douglas K. Rex, MD  Clinical Gastroenterology and Hepatology 
Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up  David W. Orr, Phillip M. Harrison, John Devlin,
CGH Receives High Impact Factor
Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany  Hermann Brenner, Lutz Altenhofen,
Celiac Disease and Persistent Symptoms
Volume 148, Issue 7, Pages (June 2015)
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review  Vincent Mukkada, Gary W. Falk, Christian S. Eichinger,
Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali 
Todd H. Baron, Patrick S. Kamath, Robert D. McBane 
Should the Reflex Be Reflux
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Granular Cell Tumor in Colonic Polyp Found on Screening Colonoscopy
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Miles Basil, Anita Pudusseri, Robert Lowe 
Jessica L. Mellinger, Michael L. Volk 
Atif Saleem, David H. Bruining, Todd H. Baron 
Eighty-Year-Old Patient With History of a Twelve Millimeter Adenomatous Polyp Resected at Age of Seventy-Five Years  David Lieberman  Clinical Gastroenterology.
Activity-Based Costing and Management in a Hospital-Based GI Unit
Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A
Cainan Foltz, Williamson Strum 
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima 
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Volume 143, Issue 2, Pages e1 (August 2012)
Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer  Shari S. Rogal, Paul F. Pinsky, Robert E.
Kaposi’s Sarcoma Involving the Gastrointestinal Tract
Swati G. Patel, Dennis J. Ahnen 
Prevalence of Eosinophilic Esophagitis in the United States
Allison E. Anderson, Kevin A. Henry, N. Jewel Samadder, Ray M
Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases  Ashwin N. Ananthakrishnan, Christopher.
Deborah A. Fisher, Joseph Galanko, Tara K. Dudley, Nicholas J. Shaheen 
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Sahil Mittal, Yu–Li Lin, Alai Tan, Yong–Fang Kuo, Hashem B
Colorectal Cancer Screening: How to Stop a Moving Target
A Program to Enhance Completion of Screening Colonoscopy Among Urban Minorities  Lea Ann Chen, Stephanie Santos, Lina Jandorf, Jennifer Christie, Anabella.
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Heiko Pohl, Douglas J. Robertson 
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Alan Bonder, MD, Nezam H. Afdhal, MD 
Thrombocytopenia With Abnormal Liver Function Tests
Benedetto Mangiavillano, Monica Arena, Enzo Masci 
Screening and Surveillance Colonoscopy in Chronic Crohn's Colitis: Results of a Surveillance Program Spanning 25 Years  Sonia Friedman, Peter H. Rubin,
Gastrointestinal Tuberculosis: An Unusual Presentation
Volume 137, Issue 2, Pages e2 (August 2009)
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Hairball in the Stomach: A Case of Gastric Trichobezoar
Black and White Liver Clinical Gastroenterology and Hepatology
Adverse Outcomes: Why Bad Things Happen to Good People
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Issue Highlights Clinical Gastroenterology and Hepatology
Many Patients Who Undergo Surgery for Colorectal Cancer Receive Surveillance Colonoscopies Earlier Than Recommended by Guidelines  Amanpal Singh, Yong–Fang.
The Role of Psychosocial Care in Adapting to Health Care Reform
Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Spiral Enteroscopy Is Safe and Effective for an Elderly United States Population of Patients With Numerous Comorbidities  Joel R. Judah, Peter V. Draganov,
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Impact of the 2008–2009 Economic Recession on Screening Colonoscopy Utilization Among the Insured  Spencer D. Dorn, David Wei, Joel F. Farley, Nilay D. Shah, Nicholas J. Shaheen, Robert S. Sandler, Michael D. Kappelman  Clinical Gastroenterology and Hepatology  Volume 10, Issue 3, Pages 278-284 (March 2012) DOI: 10.1016/j.cgh.2011.11.020 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Screening colonoscopy utilization among insurance beneficiaries before and during the economic recession. Black boxes represent rates of screening colonoscopy each month. Solid lines represent rate predicted by segmented regression models before and during the economic recession. Broken line represents recession-era rates that would have been expected based on projections of prerecession trends. P value for test of trend change between prerecession to recession periods. Numerical data displayed in Appendix Table 1. Data source: LifeLink Health Plan Claims Database (January 2005 through June 2009). Clinical Gastroenterology and Hepatology 2012 10, 278-284DOI: (10.1016/j.cgh.2011.11.020) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Screening colonoscopy utilization among insurance beneficiaries of plans with high (≥$300) and low (≤$50) OOP costs before and during the recession. Black boxes represent rates of screening colonoscopy each month, and solid black line represents screening colonoscopy rates predicted by segmented regression models before and during the economic recession among members of plans with low OOP costs. Grey diamonds represent rates of screening colonoscopy each month, and solid grey line represents screening colonoscopy rates predicted by segmented regression models before and during the economic recession among members of plans with high OOP costs. Broken line represents recession-era rates that would have been expected based on projections of prerecession trends. Net decrease represents the difference between these recession-era predicted rates and observed rates. P value for test of trend change from prerecession to recession period between plans with high OOP costs and low OOP costs. Numerical data displayed in Appendix Table 2. Data source: LifeLink Health Plan Claims Database (January 2005 through June 2009). Clinical Gastroenterology and Hepatology 2012 10, 278-284DOI: (10.1016/j.cgh.2011.11.020) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Median OOP costs for screening colonoscopy. Black boxes represent the median OOP cost incurred for all colonoscopies performed each month. Solid lines represent median cost predicted by segmented regression models before and during the economic recession. Broken line represents what the expected recession-era OOP cost would have been based on projection of prerecession trends. Net decrease represents the difference between median costs during the recession that would have been expected based on prerecession trends and the median costs that were actually observed. P value is for test of trend change between prerecession to recession periods. Numercial data displayed in Appendix Table 3. Data source: LifeLink Health Plan Claims Database (January 2005 through June 2009). Clinical Gastroenterology and Hepatology 2012 10, 278-284DOI: (10.1016/j.cgh.2011.11.020) Copyright © 2012 AGA Institute Terms and Conditions